← Back to Search

Amino Acid

Test Lysine Intake for Exclusive Breastfeeding

N/A
Recruiting
Led By Rajavel Elango
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 hours
Awards & highlights

Study Summary

This trial aims to determine how much lysine women who are exclusively breastfeeding their 3-4 month old infants need, and how this changes once the infants start eating solid foods at 9-10

Who is the study for?
This trial is for women who are exclusively breastfeeding a single infant aged 3-4 months. It's also for those same mothers when their infants transition to complementary feeding at 9-10 months. Participants must be healthy with no dietary restrictions that could affect the study.Check my eligibility
What is being tested?
The study is testing different levels of lysine, an important amino acid, in the diets of breastfeeding women. Using protein shakes with varying lysine content, researchers will measure how this affects protein synthesis and nutrition during lactation and after introducing solid foods to infants.See study design
What are the potential side effects?
Since the intervention involves only dietary adjustments within normal nutritional ranges, significant side effects are not expected. However, minor digestive changes may occur due to variations in diet.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Carbon 13 Oxidation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Test Lysine IntakeExperimental Treatment1 Intervention
Randomly assigned one of 7 test lysine intakes that range from deficient to excess (12mg/kg/d to 84mg/kg/d). Participants may complete up to 4 study days, at different randomly assigned intakes.

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,345 Previous Clinical Trials
26,453,499 Total Patients Enrolled
University of British ColumbiaLead Sponsor
1,419 Previous Clinical Trials
2,467,153 Total Patients Enrolled
Rajavel ElangoPrincipal InvestigatorUniversity of British Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the specific eligibility criteria for individuals who can participate in this research endeavor?

"Candidates must be within the age range of 20 to 40 and exhibit lactation in order to qualify for participation. Approximately 15 individuals will be accepted into this research study."

Answered by AI

Are there currently any available slots for new participants in this medical trial?

"Per clinicaltrials.gov, this study is currently open for enrollment. It was initially listed on 1/1/2024 and most recently revised on 4/10/2024."

Answered by AI

Can individuals who have reached the age of 50 participate in this particular study?

"To be considered for inclusion in this study, individuals must be between 20 and 40 years old."

Answered by AI

What is the current sample size of patients involved in this clinical investigation?

"Affirmative. Information listed on clinicaltrials.gov highlights the ongoing recruitment of subjects for this trial. The study was initially disclosed on January 1st, 2024 and its last revision was made on April 10th, 2024. Enrollment is open for a total of 15 participants at one designated site."

Answered by AI
~10 spots leftby Mar 2025